Cleared Traditional

Quantum Perfusion Arterial Cannula Graft (K203057) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K203057 · Qura S.R.L · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2021
Decision
265d
Days
Class 2
Risk

K203057 is an FDA 510(k) clearance for the Quantum Perfusion Arterial Cannula Graft. Classified as Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (product code DWF), Class II - Special Controls.

Submitted by Qura S.R.L (Mirandola, IT). The FDA issued a Cleared decision on June 30, 2021 after a review of 265 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.4210 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Qura S.R.L devices

Submission Details

510(k) Number K203057 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 08, 2020
Decision Date June 30, 2021
Days to Decision 265 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
140d slower than avg
Panel avg: 125d · This submission: 265d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.4210
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DWF Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass

All 121
Devices cleared under the same product code (DWF) and FDA review panel - the closest regulatory comparables to K203057.
Quantum Perfusion Single Lumen Cannula 22F, Quantum Perfusion Dual Lumen Cannula 31F, Quantum Perfusion Dual Lumen Cannula 27F, Quantum Perfusion Dual Lumen Cannula 24F
K203067 · Qura S.R.L · Nov 2021
AngioVac F18 85
K212386 · AngioDynamics, Inc. · Sep 2021
Bio-Medicus Life Support Catheter and Introducer
K201100 · Medtronic, Inc. · Jul 2021
Michler-Kapp Cardiovascular Vent Catheter
K200289 · Kapp Surgical Instrument, Inc. · Jan 2021
R501 aortic root cannula without vent line, R502 aortic root cannula with vent line
K200612 · Sorin Group Italia S.R.L. · Nov 2020
QuickDraw Venous Cannula
K200499 · Edwards Lifesciences, LLC · Mar 2020